Using CT scans to predict outcomes after lung blood clots
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial uses an artificial intelligence (AI) system to read CT scan images of the lungs and predict outcomes after a pulmonary embolism (a blood clot in the lung). It may help doctors identify who is at higher risk, so treatment decisions can be faster and more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a pulmonary embolism using a CT pulmonary angiography scan
- You are not pregnant
- You did not receive a blood-clot “reperfusion” treatment before being admitted to the hospital
- Your CT scan measurement data and key heart blood tests are available (CT parameters, echocardiography, troponin I, and NT-proBNP)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a tool that uses CT scan results and heart blood tests to predict the chance of serious outcomes after an acute pulmonary embolism (a blood clot in the lung). It may help doctors identify higher-risk patients sooner.
This study is testing whether artificial intelligence can help doctors read CT scans of the lung's blood vessels more accurately and quickly. If you're an adult with a suspected pulmonary embolism who has already had a good-quality CT scan, you may be able to help improve how these scans are interpreted.
This study uses artificial intelligence to look at imaging scans from people who might have a pulmonary embolism (a blood clot in the lungs). It aims to help doctors better diagnose and treat this condition.
This study tests a new, non-invasive imaging method called pulsatile electrical impedance tomography (EIT) to help diagnose and monitor acute pulmonary embolism (blood clots in the lungs). It may provide a faster or safer way to detect clots compared to standard CT scans, especially for patients who cannot have contrast dye.
This study tests a new type of CT scan (photon-counting CT) to see if it's better at finding small blood clots in the lungs. If you have symptoms like sudden shortness of breath, chest pain, or fainting and doctors suspect a blood clot, this trial may help confirm the diagnosis with clearer images.
This trial tests an artificial intelligence tool that helps doctors identify lung changes caused by viral pneumonia, like COVID-19, on CT scans. It may lead to faster and more accurate diagnosis for patients.
Hear when a new Pulmonary Embolism and Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.